These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4291173)

  • 1. [On motor end-plate diseases with special reference to myasthenia gravis].
    Oosterhuis HJ
    Verh Dtsch Ges Inn Med; 1965; 71():238-54. PubMed ID: 4291173
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of myasthenia with corticotropic hormones].
    Goulon M; Barois A; Gajdos P; Grosbuis S; Joron MH; Bennaiche M
    Sem Hop; 1972 Dec; 48(51):3371-5. PubMed ID: 4347494
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immunity phenomenon and neuromuscular diseases].
    Igata A
    Naika; 1968 Feb; 21(2):214-21. PubMed ID: 4301008
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis and autoimmunity.
    Whitaker JN
    Adv Intern Med; 1980; 26():489-510. PubMed ID: 6164271
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the therapy of myasthenia gravis. (Presentation of a case)].
    Henriquet F; Balestra L
    Minerva Anestesiol; 1970 Apr; 36(4):277-81. PubMed ID: 4320560
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
    Ruff RL; Lennon VA
    Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of myasthenia gravis.
    Dipalma JR
    Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
    [No Abstract]   [Full Text] [Related]  

  • 10. [ACTH or adrenocortical hormone therapy in myasthenia gravis, myotonia and herpes zoster].
    Takahashi A
    Horumon To Rinsho; 1968 Mar; 16(3):177-88. PubMed ID: 4300299
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs and myasthenia gravis. An update.
    Wittbrodt ET
    Arch Intern Med; 1997 Feb; 157(4):399-408. PubMed ID: 9046891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of myasthenia gravis associated with Hashimoto's disease; with special reference to the mechanism of autoimmune disease].
    Igata A; Takida K; Tsukagoshi H; Toyokura Y
    Shinkei Kenkyu No Shimpo; 1970; 14(3):471-5. PubMed ID: 5537120
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis and premature ovarian failure.
    Ryan MM; Jones HR
    Muscle Nerve; 2004 Aug; 30(2):231-3. PubMed ID: 15266640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diseases of the motoric end plate including myasthenia gravis].
    Struppler A
    Wien Klin Wochenschr; 1967 Aug; 79(33):620-2. PubMed ID: 4298887
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pseudoparalytic myasthenia gravis as autoimmune disease].
    Ricken D
    Internist (Berl); 1970 Jan; 11(1):25-30. PubMed ID: 5000105
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current therapeutic aspects of myasthenia gravis].
    Avilés Mejias S; Ledro Molina D; Garrido Peralta M
    Rev Clin Esp; 1981 Oct; 163(2):139-44. PubMed ID: 6276943
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concurrence of myasthenia gravis, polymyositis, thyroiditis and eosinophilia in a patient with type B1 thymoma].
    Inoue M; Kojima Y; Shinde A; Satoi H; Makino F; Kanda M; Shibasaki H
    Rinsho Shinkeigaku; 2007 Jul; 47(7):423-8. PubMed ID: 17710886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.